切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 137 -140. doi: 10.3877/cma.j.issn.2095-3224.2018.02.007

所属专题: 文献

论著

二甲双胍对高葡萄糖环境下结肠癌细胞增殖和侵袭的影响
刘付俊业1, 吴共发2,(), 邱丽浈3, 曾宇婷2, 黄绮亭2   
  1. 1. 518109 深圳市龙华区人民医院消化内科
    2. 511300 广州市增城区人民医院(中山大学孙逸仙纪念医院增城院区)病理科
    3. 511300 广州市增城区人民医院(中山大学孙逸仙纪念医院增城院区)内三科
  • 收稿日期:2017-06-10 出版日期:2018-04-25
  • 通信作者: 吴共发
  • 基金资助:
    广东省医学科研基金(No.A2016422)

Effects of metformin on proliferation and invasion in colon carcinoma cell in the high glucose environment

Junye Liufu1, Gongfa Wu2,(), Lizhen Qiu3, Yuting Zeng2, Qiting Huang2   

  1. 1. Department of Gastroenterology, Longhua District People′s Hospital of Shenzhen City, Shenzhen 518109, China
    2. Department of Pathology, Zengcheng District People′s Hospital of Guangzhou City, Guangzhou 511300, China
    3. Third Department of Internal Medicine, Zengcheng District People′s Hospital of Guangzhou City, Guangzhou 511300, China
  • Received:2017-06-10 Published:2018-04-25
  • Corresponding author: Gongfa Wu
  • About author:
    Corresponding author: Wu Gongfa, Email:
引用本文:

刘付俊业, 吴共发, 邱丽浈, 曾宇婷, 黄绮亭. 二甲双胍对高葡萄糖环境下结肠癌细胞增殖和侵袭的影响[J]. 中华结直肠疾病电子杂志, 2018, 07(02): 137-140.

Junye Liufu, Gongfa Wu, Lizhen Qiu, Yuting Zeng, Qiting Huang. Effects of metformin on proliferation and invasion in colon carcinoma cell in the high glucose environment[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(02): 137-140.

目的

观察二甲双胍在高葡萄糖环境下对人结肠癌细胞系SW480增殖和侵袭的影响,并探讨其可能的机制。

方法

通过Western blot方法检测SW480细胞在高葡萄糖及不同浓度二甲双胍干预后E-cadherin和Vimentin的表达水平,并应用CCK-8法及Transwell侵袭实验检测细胞增殖及侵袭能力的变化。

结果

高葡萄糖作用不同时间后均能促进结肠癌细胞增殖,二甲双胍能抑制结肠癌细胞的增殖,并呈时间——剂量依赖性。20 mmol/L浓度二甲双胍干预48 h后,Transwell侵袭实验结果显示细胞穿膜数为(40.18±2.22)%,明显低于高糖组和对照组(F=49.403,P<0.001);Western blot结果显示E-cadherin表达明显增强,Vimentin表达明显减弱。

结论

高葡萄糖环境能促进结肠癌细胞生长,二甲双胍能明显抑制有或无高葡萄糖环境下结肠癌的增殖和侵袭能力,其机制可能与调节上皮——间质转化(EMT)过程有关。

Objective

To investigate the effects of metformin on proliferation and invasion in human colon carcinoma cell SW480 in the high glucose environment and explore the possible underlying mechanisms.

Methods

Western blot was applied to assess the expressions of E-cadherin and Vimentin in SW480 cells treated with high glucose medium and different concentration metformin, respectively. Cell proliferation and invasion were detected by Cell Counting Kit-8 (CCK-8) assay and transwell invasion assay, respectively.

Results

High glucose could promote proliferation of SW480 cells at different action time. After intervened by different concentration of metformin, metformin decreased the proliferation of SW480 in a dose-and time dependent manner. Comparing with the high glucose group and control group, after 48 h of metformin (20 mmol/L) intervention to SW480, transwell invasion assay indicated that the cells crossing the membrane were significantly decreased to (40.18±2.22)% (F=49.403, P<0.001). Western blot showed that the expressions of E-cadherin were obviously increased, while Vimentin were apparently decreased.

Conclusion

High glucose environment can promote the growth of colon carcinoma cells. Metformin causes a distinct reduction of cells proliferation and invasion in colon carcinoma cells with or without high glucose environment, its molecular mechanism may involve in metformin have a role in the regulation of epithelial-mesenchymal transition.

图1 高糖组与对照组不同时间点的细胞增殖情况
图2 不同浓度二甲双胍对高糖环境下SW480细胞的增殖影响
图3 二甲双胍对高糖环境下结肠癌细胞EMT标记物的表达影响
[1]
Lee MS, Hsu CC, Wahlqvist ML, et al. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancerinc idences in Taiwanese: a representative population prospective cohort study of 800, 000 individuals [J]. BMC Cancer, 2011, 11: 20
[2]
Nie Z, Zhu H, Gu M. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis [J]. Pharm Biol, 2016, 54(11): 2636-2642.
[3]
de Kort S, Simons CC, van den Brandt PA, et al. Diabetes mellitustype 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer [J]. Eur J Gastroenterol Hepatol, 2016, 28(8): 896-903.
[4]
Coyle C, Cafferty FH, Vale C, et al. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis [J]. Ann Oncol, 2016, 27(12): 2184-2195.
[5]
Zakikhani M, Dowling RJ, Sonenberg N, et al. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase [J]. Cancer Prev Res(Phila), 2008, 1(5): 369-375.
[6]
Tomimoto A, Endo H, Sugiyama M, et al. Metformin suppresses intestinal polyp growth in ApcMin/+ mice [J]. Cancer Sci, 2008, 99(11): 2136-2141.
[7]
朱智峰,梁琳琅. 二甲双胍对结肠癌细胞增殖、周期及凋亡的影响 [J]. 中国医科大学学报, 2012, 41(2): 115-119.
[8]
郭娜,逢曙光. 二甲双胍抑制晚期糖基化终产物诱导的大肠癌细胞侵袭和上皮间质转化 [J]. 中国老年学杂志, 2015, 35(19): 5374-5377.
[9]
Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J]. Oncogene, 2008, 27(25): 3576-3586.
[10]
王静璐,史惠蓉,谢娅, 等.二甲双胍对不同分化程度的子宫内膜癌细胞增殖的影响及相关作用机制 [J]. 中华妇产科杂志, 2015, 65(9): 685-691.
[11]
Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis [J]. Mol Oncol, 2017, 11(1): 28-39.
[12]
Valaee S, Yaghoobi MM, Shamsara M. Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner [J]. PLoS One, 2017, 12(3): e0174486.
[13]
Zhao Z, Cheng X, Wang Y, et al. Metformin inhibits theIL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis [J]. PLoS One, 2014, 9(4): e95884.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 付佳, 肖海敏, 武曦, 冯涛, 师帅. 年龄校正查尔森合并症指数对腹腔镜结直肠癌围手术期并发症的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 336-341.
[5] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[6] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[7] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[8] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[11] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[12] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[13] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[14] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[15] 方辉, 李菲, 张帆, 魏强, 陈强谱. 外源性瘦素对梗阻性黄疸大鼠肠黏膜增殖的影响[J]. 中华临床医师杂志(电子版), 2023, 17(05): 575-580.
阅读次数
全文


摘要